BIOMATRIX INC
10-Q, EX-27, 2000-11-14
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Previous: BIOMATRIX INC, 10-Q, 2000-11-14
Next: WASTEMASTERS INC, NT 10-Q, 2000-11-14



<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM
BIOMATRIX, INC. FORM 10-Q FOR THE QUARTER ENDED SEPTEMBER 30, 2000 AND
IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>
<MULTIPLIER> 1,000

<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-START>                             JAN-01-2000
<PERIOD-END>                               SEP-30-2000
<CASH>                                          46,700
<SECURITIES>                                         0
<RECEIVABLES>                                   12,600
<ALLOWANCES>                                         0
<INVENTORY>                                      8,200
<CURRENT-ASSETS>                                73,300
<PP&E>                                          39,700
<DEPRECIATION>                                       0
<TOTAL-ASSETS>                                 113,800
<CURRENT-LIABILITIES>                           11,300
<BONDS>                                         11,100
                                0
                                          0
<COMMON>                                             0
<OTHER-SE>                                      91,400
<TOTAL-LIABILITY-AND-EQUITY>                   113,800
<SALES>                                         57,300
<TOTAL-REVENUES>                                66,400
<CGS>                                           17,100
<TOTAL-COSTS>                                   45,500
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                 700
<INCOME-PRETAX>                                 22,500
<INCOME-TAX>                                     9,200
<INCOME-CONTINUING>                                  0
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                    13,300
<EPS-BASIC>                                       0.57
<EPS-DILUTED>                                     0.55


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission